APA (7th ed.) Citation

Wang, A., Xu, Y., Fei, Y., & Wang, M. (2020). The role of immunosuppressive agents in the management of severe and refractory immune‐related adverse events. Asia-Pacific journal of clinical oncology, 16(4), 201-210. https://doi.org/10.1111/ajco.13332

Chicago Style (17th ed.) Citation

Wang, Anqi, Yan Xu, Yunyun Fei, and Mengzhao Wang. "The Role of Immunosuppressive Agents in the Management of Severe and Refractory Immune‐related Adverse Events." Asia-Pacific Journal of Clinical Oncology 16, no. 4 (2020): 201-210. https://doi.org/10.1111/ajco.13332.

MLA (9th ed.) Citation

Wang, Anqi, et al. "The Role of Immunosuppressive Agents in the Management of Severe and Refractory Immune‐related Adverse Events." Asia-Pacific Journal of Clinical Oncology, vol. 16, no. 4, 2020, pp. 201-210, https://doi.org/10.1111/ajco.13332.